THE CHOICE OF STRATEGY IN THE TREATMENT OF INTERMITTENT CLAUDICATION - A DECISION TREE APPROACH

被引:11
|
作者
TROENG, T
BERGQVIST, D
JANZON, L
JENDTEG, S
LINDGREN, B
机构
[1] Department of Surgery in Karlskrona, the Swedish Institute for Health Economics in Lund
[2] Department of Surgery in Malmö, the Swedish Institute for Health Economics in Lund
[3] Department of Community Health Sciences in Malmö, the Swedish Institute for Health Economics in Lund
[4] IHE, the Swedish Institute for Health Economics in Lund
来源
EUROPEAN JOURNAL OF VASCULAR SURGERY | 1993年 / 7卷 / 04期
关键词
DECISION ANALYSIS; INTERMITTENT CLAUDICATION; CHOICE OF TREATMENT; VASCULAR REGISTRY;
D O I
10.1016/S0950-821X(05)80263-4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: to compare possible outcomes of the non-operative treatment for intermittent claudication with that of surgery. Design: decision tree approach using published and vascular registry data. The valuation of clinical outcomes was estimated by index weights using the Rosser index and the Quality of Well-Being scale. Setting: routine health care in Sweden. Materials: published data on 224 non-operatively treated claudicants and data from 805 claudicants treated with surgery or angioplasty from the Swedvasc registry. No diabetics were included. Chief outcome measure: expected utility value at one year after decision on treatment given the clinical data and the estimated health status valuations. Main results: it was possible to identify a success rate for surgery above which it was the better alternative. However, depending on which of two health indices that was used, and if reconstruction was supra- or infrainguinal, this threshold value varied from 0-81 %. Conclusions: reliable measures of the value of outcomes have to be developed and, in addition, long-term data on outcome and costs in routine care have to be collected before a comprehensive economic assessment based on the decision tree approach can be made to support decisions on treatment for intermittent claudication. © 1993 Grune & Stratton Ltd.
引用
收藏
页码:438 / 443
页数:6
相关论文
共 50 条
  • [31] Editor's Choice - Daily Remote Ischaemic Preconditioning for Intermittent Claudication: A Sham Controlled Randomised Trial
    Eerik, Kadri
    Kasepalu, Teele
    Post, Holger
    Eha, Jaan
    Kals, Mart
    Kals, Jaak
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2025, 69 (02) : 295 - 302
  • [32] Feasibility study to evaluate cycloidal vibration therapy for the symptomatic treatment of intermittent claudication
    Atkin, Leanne
    Stephenson, John
    Ousey, Karen
    PILOT AND FEASIBILITY STUDIES, 2019, 5 (01)
  • [33] Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK
    Guest, JF
    Davie, AM
    Clegg, JP
    CURRENT MEDICAL RESEARCH AND OPINION, 2005, 21 (06) : 817 - 826
  • [34] Editor's Choice - The Effect of Supervision on Walking Distance in Patients with Intermittent Claudication: A Meta-analysis
    Gommans, L. N. M.
    Saarloos, R.
    Scheltinga, M. R. M.
    Houterman, S.
    de Bie, R. A.
    Fokkenrood, H. J. P.
    Teijink, J. A. W.
    EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2014, 48 (02) : 169 - 184
  • [35] Feasibility study to evaluate cycloidal vibration therapy for the symptomatic treatment of intermittent claudication
    Leanne Atkin
    John Stephenson
    Karen Ousey
    Pilot and Feasibility Studies, 5
  • [36] Cilostazol is effective and safe option for the treatment of intermittent claudication Results of the NOCLAUD study
    Farkas Katalin
    Jarai Zoltan
    Kolossvary Endre
    ORVOSI HETILAP, 2017, 158 (04) : 123 - 128
  • [37] Measuring treatment effects of cilostazol on clinical trial endpoints in patients with intermittent claudication
    Smith, JAM
    CLINICAL CARDIOLOGY, 2002, 25 (03) : 91 - 94
  • [38] A pooled analysis of the durability and predictors of treatment response of cilostazol in patients with intermittent claudication
    Pande, Reena L.
    Hiatt, William R.
    Zhang, Peter
    Hittel, Norbert
    Creager, Mark A.
    VASCULAR MEDICINE, 2010, 15 (03) : 181 - 188
  • [39] Value of Information Analyses of Economic Randomized Controlled Trials: The Treatment of Intermittent Claudication
    Koerkamp, Bas Groot
    Spronk, Sandra
    Stijnen, Theo
    Hunink, M. G. Myriam
    VALUE IN HEALTH, 2010, 13 (02) : 242 - 250
  • [40] Intermittent vacuum treatment with VacuMed does not improve peripheral artery disease or walking capacity in patients with intermittent claudication
    Afzelius, Pia
    Molsted, Stig
    Tarnow, Lise
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2018, 78 (06) : 456 - 463